Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Jan;64(1):108–112. doi: 10.1136/jnnp.64.1.108

Prophylactic antiepileptic agents after head injury: a systematic review

G Schierhout 1, I Roberts 1
PMCID: PMC2169898  PMID: 9436738

Abstract

OBJECTIVE—To determine the effectiveness and safety of prophylactic antiepileptic agents in the management of acute traumatic head injury.
METHODS—Systematic review of randomised controlled trials identified using MEDLINE, EMBASE, CINAHL, Dewent Biotechnology abstracts, and specialised databases of randomised controlled trials, by searching reference lists and contacting investigators.
RESULTS— Ten eligible randomised controlled trials were identified, including 2036 patients. The pooled relative risk (RR) for early seizure prevention was 0.34 (95% confidence interval (95%CI) 0.21-0.54); based on this estimate, for every 100 patients treated, 10 would be kept seizure free in the first week. Seizure control in the acute phase was not accompanied by a reduction in mortality (RR=1.15; 95% CI 0.89-1.51), a reduction in death and neurological disability (RR=1.49; 95% CI 1.06-2.08 for carbamazepine and RR=0.96; 95% CI 0.72-1.26 for phenytoin) or a reduction in late seizures (pooled RR=1.28; 95% CI 0.90-1.81). The pooled relative risk for skin rashes was 1.57 (95% CI 0.90-2.75).
CONCLUSIONS—Prophylactic antiepileptic drugs are effective in reducing early seizures, but there is no evidence that treatment with such drugs reduces the occurrence of late seizures, or has any effect on death and neurological disability. Insufficient evidence is available to establish the net benefit of prophylactic treatment at any time after injury.



Full Text

The Full Text of this article is available as a PDF (117.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertch K. E., Norton J. A., Young A. B., Rapp R. P., Tibbs P. A. A comparative study of laboratory parameters in head-injured patients receiving either phenytoin or placebo for 24 months. Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):561–566. doi: 10.1177/106002808501900713. [DOI] [PubMed] [Google Scholar]
  2. Cook R. J., Sackett D. L. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995 Feb 18;310(6977):452–454. doi: 10.1136/bmj.310.6977.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dickersin K., Scherer R., Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994 Nov 12;309(6964):1286–1291. doi: 10.1136/bmj.309.6964.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dikmen S. S., Temkin N. R., Miller B., Machamer J., Winn H. R. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA. 1991 Mar 13;265(10):1271–1277. [PubMed] [Google Scholar]
  5. Ghajar J., Hariri R. J., Narayan R. K., Iacono L. A., Firlik K., Patterson R. H. Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med. 1995 Mar;23(3):560–567. doi: 10.1097/00003246-199503000-00023. [DOI] [PubMed] [Google Scholar]
  6. Glötzner F. L., Haubitz I., Miltner F., Kapp G., Pflughaupt K. W. Anfallsprophylaxe mit Carbamazepin nach schweren Schädelhirnverletzungen. Neurochirurgia (Stuttg) 1983 May;26(3):66–79. doi: 10.1055/s-2008-1053615. [DOI] [PubMed] [Google Scholar]
  7. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., McQuay H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17(1):1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  8. Manaka S. Cooperative prospective study on posttraumatic epilepsy: risk factors and the effect of prophylactic anticonvulsant. Jpn J Psychiatry Neurol. 1992 Jun;46(2):311–315. doi: 10.1111/j.1440-1819.1992.tb00865.x. [DOI] [PubMed] [Google Scholar]
  9. McQueen J. K., Blackwood D. H., Harris P., Kalbag R. M., Johnson A. L. Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis. J Neurol Neurosurg Psychiatry. 1983 Oct;46(10):899–904. doi: 10.1136/jnnp.46.10.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pechadre J. C., Lauxerois M., Colnet G., Commun C., Dimicoli C., Bonnard M., Gibert J., Chabannes J. Prévention de l'épilepsie post-traumatique tardive par phénytoïne dans les traumatismes crâniens graves. Suivi durant 2 ans. Presse Med. 1991 May 11;20(18):841–845. [PubMed] [Google Scholar]
  11. Popek K., Musil F. Klinický pokus o prevenci posttraumatické epilepsie po tezkých zraneních mozku u dospelých. Cas Lek Cesk. 1969 Jan;108(5):133–147. [PubMed] [Google Scholar]
  12. Rapport R. L., 2nd, Penry J. K. A survey of attitudes toward the pharmacological prophylaxis of posttraumatic epilepsy. J Neurosurg. 1973 Feb;38(2):159–166. doi: 10.3171/jns.1973.38.2.0159. [DOI] [PubMed] [Google Scholar]
  13. Schulz K. F., Chalmers I., Hayes R. J., Altman D. G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995 Feb 1;273(5):408–412. doi: 10.1001/jama.273.5.408. [DOI] [PubMed] [Google Scholar]
  14. Servít Z., Musil F. Prophylactic treatment of posttraumatic epilepsy: results of a long-term follow-up in Czechoslovakia. Epilepsia. 1981 Jun;22(3):315–320. doi: 10.1111/j.1528-1157.1981.tb04115.x. [DOI] [PubMed] [Google Scholar]
  15. Tasker R. C., Coyle J. T., Vornov J. J. The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci. 1992 Nov;12(11):4298–4308. doi: 10.1523/JNEUROSCI.12-11-04298.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Temkin N. R., Dikmen S. S., Wilensky A. J., Keihm J., Chabal S., Winn H. R. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990 Aug 23;323(8):497–502. doi: 10.1056/NEJM199008233230801. [DOI] [PubMed] [Google Scholar]
  17. Thompson S. G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994 Nov 19;309(6965):1351–1355. doi: 10.1136/bmj.309.6965.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vartanian M. G., Cordon J. J., Kupina N. C., Schielke G. P., Posner A., Raser K. J., Wang K. K., Taylor C. P. Phenytoin pretreatment prevents hypoxic-ischemic brain damage in neonatal rats. Brain Res Dev Brain Res. 1996 Sep 2;95(2):169–175. doi: 10.1016/0165-3806(96)00073-9. [DOI] [PubMed] [Google Scholar]
  19. Young B., Rapp R. P., Norton J. A., Haack D., Tibbs P. A., Bean J. R. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg. 1983 Feb;58(2):231–235. doi: 10.3171/jns.1983.58.2.0231. [DOI] [PubMed] [Google Scholar]
  20. Young B., Rapp R. P., Norton J. A., Haack D., Tibbs P. A., Bean J. R. Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg. 1983 Feb;58(2):236–241. doi: 10.3171/jns.1983.58.2.0236. [DOI] [PubMed] [Google Scholar]
  21. Young B., Rapp R. P., Norton J. A., Haack D., Walsh J. W. Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children. Childs Brain. 1983;10(3):185–192. doi: 10.1159/000120113. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES